CN106177057A - 一种治疗高血压和血栓的中药组合物 - Google Patents
一种治疗高血压和血栓的中药组合物 Download PDFInfo
- Publication number
- CN106177057A CN106177057A CN201610703425.8A CN201610703425A CN106177057A CN 106177057 A CN106177057 A CN 106177057A CN 201610703425 A CN201610703425 A CN 201610703425A CN 106177057 A CN106177057 A CN 106177057A
- Authority
- CN
- China
- Prior art keywords
- fructus
- radix
- chinese medicine
- medicine composition
- fructus citri
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 47
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 29
- 239000000203 mixture Substances 0.000 title claims abstract description 23
- 208000007536 Thrombosis Diseases 0.000 title claims abstract description 20
- 210000000582 semen Anatomy 0.000 claims abstract description 11
- 229940079593 drug Drugs 0.000 claims abstract description 9
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 36
- 239000007788 liquid Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 10
- 239000012567 medical material Substances 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000011084 recovery Methods 0.000 claims description 5
- 240000000249 Morus alba Species 0.000 claims description 3
- 235000008708 Morus alba Nutrition 0.000 claims description 3
- 238000002481 ethanol extraction Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 2
- 241000208367 Euonymus Species 0.000 claims 1
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 230000036772 blood pressure Effects 0.000 description 7
- 230000036541 health Effects 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 238000003304 gavage Methods 0.000 description 6
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 5
- 229960001597 nifedipine Drugs 0.000 description 5
- 208000024172 Cardiovascular disease Diseases 0.000 description 4
- 239000003146 anticoagulant agent Substances 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000002537 thrombolytic effect Effects 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000002785 anti-thrombosis Effects 0.000 description 3
- 230000035487 diastolic blood pressure Effects 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 239000002947 C09CA04 - Irbesartan Substances 0.000 description 2
- 108010088842 Fibrinolysin Proteins 0.000 description 2
- 239000009277 Panax notoginseng extract Substances 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- YCPOHTHPUREGFM-UHFFFAOYSA-N irbesartan Chemical compound O=C1N(CC=2C=CC(=CC=2)C=2C(=CC=CC=2)C=2[N]N=NN=2)C(CCCC)=NC21CCCC2 YCPOHTHPUREGFM-UHFFFAOYSA-N 0.000 description 2
- 229960002198 irbesartan Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000003071 parasitic effect Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 238000011285 therapeutic regimen Methods 0.000 description 2
- 230000001732 thrombotic effect Effects 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 102000013566 Plasminogen Human genes 0.000 description 1
- 108010051456 Plasminogen Proteins 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229940121792 Thiazide diuretic Drugs 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 210000001168 carotid artery common Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 229940001501 fibrinolysin Drugs 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002003 hydrochlorothiazide Drugs 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 208000037921 secondary disease Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000003451 thiazide diuretic agent Substances 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种治疗高血压和血栓的中药组合物,其由以下重量份的原料药制成:佛手3‑9、黄芩3‑10、桑白皮5‑15、牡蛎9‑30、桑叶5‑9、葛根9‑15、白芍5‑15、牛膝6‑15、砂仁3‑6、连翘6‑15、香橼3‑9、夏枯草9‑15、栀子3‑10、茵陈6‑15、钩藤3‑12、酸枣仁9‑15、地骨皮6‑15、玉竹6‑12、桑寄生9‑15。
Description
一技术领域
本发明涉及中药领域,具体地说,本发明涉及治疗高血压和血栓的中药组合物。
二背景技术
目前中国心脑血管疾病的总发病率和死亡率已接近发达国家的水平,居中国人死亡原因之首(中国居民营养与慢性病状况报告2015国家卫生与计划生育委员会官网),而高血压和血栓类疾病是其中的前两位的危险因素。
高血压病是一种原因尚未完全阐明,以体循环动脉压增高为特征,可伴有心脏、血管、脑和肾等器官功能性或器质性改变的全身性疾病。高血压最大的危害是引发心血管病发生。目前全球高血压患病数大约为12亿,其中40~70岁的高血压患者,收缩压每升高20mmHg或舒张压每升高10mmHg,心血管发病危险增加2倍。据2012年卫计委组织的全国居民营养与健康状况调查显示(卫计委网站),中国≥18岁居民高血压患病率为18.8%,估计全国患病数1.6亿。与1991年比较,患病率上升31%。因此,有效治疗高血压,降低心血管病发生的风险是医学界关注的热点。
血栓性疾病也是一类严重危害人类健康和生命的疾病,可累及全身各个器官及系统,其发病率、致残率和死亡率都很高。血栓是指血液成分在血液流动过程中,在血管或心脏内膜表面形成的一种半凝块状物质。促使血栓形成的因素很多,主要有血管内皮损伤、内外凝血系统异常和血流动力学异常等。
目前西医无标准的高血压病治疗方法。临床上一般可采用血管紧张素转换酶抑制剂或噻嗪类利尿剂治疗(如硝苯地平片香雪制药股份有限公司等主要成分为硝苯地平片)。但是,一方面,这些药物的长期有效性和安全性评价研究仍需进行,另一方面,患者对常用西药降压药产生不同程度的耐药性。现有的西药溶栓药物的主要作用机制是直接或间接激活纤维蛋白溶酶原,使其转变为纤维蛋白溶酶(如厄贝沙坦片 赛诺菲 主要成分为厄贝沙坦氢氯噻嗪),纤溶酶可以溶解血栓中的纤维蛋白,从而溶解血栓。但此类药物比较容易引起出血并发症,造成皮肤、精神、血液、心血管、泌尿等系统的很多不良反应。
高血压和血栓经常由于血脂等原因共同发生,而且两者共同出现会相互促进造成更大的健康风险。现有西药的作用均为单纯的降压或溶栓,现有市售中成药也没有能同时起两种作用的品种(如杜仲降压片康普药业股份有限公司主要成为为杜仲、益母草、夏枯草、黄岑、钩藤;复方血栓通胶囊广东众生药业股份有限公司主要成分为三七、黄芪、丹参、玄参),有部分专利申请声称能同时降压和溶栓,但并无严谨确切的数据证明同时具有这两种作用。
三发明内容
针对上述问题,本发明提供了一种能同时治疗高血压和血栓的中药组合物,在传统降压和溶栓中药材,如夏枯草、牡蛎、黄芩等的基础上,通过合理配伍,实现了确切的降压和溶栓功效,而且无明显毒副作用。对于心血管疾病的长期防治和治疗有着良好的效果。
一方面,本发明提供了一种用于治疗高血压和血栓的中药组合物,包括以下重量份的原料:佛手3-9、黄芩3-10、香橼3-9、夏枯草9-15、酸枣仁9-15。
进一步的方面,本发明提供的一种用于治疗高血压和血栓的中药组合物,由以下重量份的原料药制成:佛手3-9、黄芩3-10、桑白皮5-15、牡蛎9-30、桑叶5-9、葛根9-15、白芍5-15、牛膝6-15、砂仁3-6、连翘6-15、香橼3-9、夏枯草9-15、栀子3-10、茵陈6-15、钩藤3-12、酸枣仁9-15、地骨皮6-15、玉竹6-12、桑寄生9-15。
进一步的方面,本发明提供的一种用于治疗高血压和血栓的中药组合物,由以下重量份的原料药制成:佛手5、黄芩10、桑白皮5、牡蛎25、桑叶5、葛根15、白芍15、牛膝10、砂仁3、连翘6、香橼3、夏枯草15、栀子10、茵陈9、钩藤3、酸枣仁9、地骨皮15、玉竹12、桑寄生9。
另一方面,本发明提供了所述治疗高血压和血栓的中药组合物的制备方法,包括步骤:
按重量份称取各种药材;
将黄芩、牡蛎、葛根、夏枯草、茵陈、地骨皮加40%的乙醇提取3次,每次加醇量为药材总重量的10倍,每次提取时间为1.5小时,合并提取液,回收乙醇至无醇味,得到醇提液;
将佛手、桑白皮、桑叶、白芍、牛膝、砂仁、连翘、香橼、栀子、钩藤、酸枣仁、玉竹、桑寄生加水提取3次,每次加水量分别为药材总重量的10倍量,每次提取时间为3小时,合并提取液,浓缩至相对密度为1.25,加入乙醇使含醇量为40体积%,混匀,放置24小时,取上清液,回收乙醇至无醇味,得到水提浓缩液;
将所得醇提液和水提浓缩液混合,得到中药组合物。
四具体实施方式
实施例1本发明中药组合物的制备
按重量份称取各种药材:佛手5、黄芩10、桑白皮5、牡蛎25、桑叶5、葛根15、白芍15、牛膝10、砂仁3、连翘6、香橼3、夏枯草15、栀子10、茵陈9、钩藤3、酸枣仁9、地骨皮15、玉竹12、桑寄生9;
将黄芩、牡蛎、葛根、夏枯草、茵陈、地骨皮加40%的乙醇提取3次,每次加醇量为药材总重量的10倍,每次提取时间为1.5小时,合并提取液,回收乙醇至无醇味,得到醇提液;
将佛手、桑白皮、桑叶、白芍、牛膝、砂仁、连翘、香橼、栀子、钩藤、酸枣仁、玉竹、桑寄生加水提取3次,每次加水量分别为药材总重量的10倍量,每次提取时间为3小时,合并提取液,浓缩至相对密度为1.25,加入乙醇使含醇量为40体积%,混匀,放置24小时,取上清液,回收乙醇至无醇味,得到水提浓缩液;
将所得醇提液和水提浓缩液混合,得到中药组合物。
实施例2本发明中药组合物的降血压效果实验
病例选择:
西医诊断标准:高血病诊断参考1999年世界卫生组织及国际高血压协会(WHO/ISH)高血压处理指南(第四次修订版);高血压病分期标准按照世界卫生组织分期标准,将高血压病分为3级。
中医证候诊断标准:痰瘀互结,毒损心络证:主症:眩晕、头痛、头如裹、胸闷、胸痛、咳吐痰涎、口唇指甲紫暗、舌下络脉青紫。舌质暗,有瘀点或瘀斑,苔白腻,脉弦滑或沉涩或结代。次症:心悸、失眠、口淡、食少,体胖。
选择60例年龄18-60岁之间,高血压病程2年以上,选择符合西医诊断标准1、2级高血压并符合中医证候诊断标准的患者。将其平均分为3组。测量各组患者的血甘油三酯和总胆固醇值,60名患者中有甘油三酯或总胆固醇值超标的为48名,其分布在三组中无统计显著差异。
用药方案:
组1:杜仲降压片康普药业股份有限公司按说明书一次1.5g,一日三次;
组2:硝苯地平片香雪制药股份有限公司按说明书10mg一次一日三次;
组3:按实施例1制备的本发明中药组合物,每次300ml,早晚各一次;
连续用药三个月,期间不使用其他药物和降压保健品,三月后进行疗效评价。
症状评分使用杜氏高血压量表,从53个客观症状和主观感觉方面评价治疗效果。
高血压疗效判定:
临床控制:血压降至正常范围,临床症状消失或症状积分减少90%以上,理化检查指标恢复正常;
显效:血压、降至正常,或舒张压虽未降至正常但达20mmHg以上,临床症状体征大部消失,或积分值减少≥70%,理化检查接近正常;
有效:血压下降≥10mmHg,并达到正常范围,或舒张压虽未降至正常,但较治疗前下降10-19mmHg,但未达到正常范围,或收缩压较治疗前下降30mmHg以上;临床症状体征好转,或积分值减少4-69%之间;理化检查好转;
无效:未达到以上标准者;
表1 各药物降压效果
临床控制 | 显效 | 有效 | 无效 | |
组1 | 1 | 7 | 7 | 5 |
组2 | 5 | 10 | 4 | 0 |
组3 | 4 | 8 | 6 | 2 |
组2一名患者在第2个月由于严重水肿退出实验。
从表1可以看出本发明中药组合物的效果明显好于控制高血压常用的中成药杜仲降压片,与硝苯地平片差距也不大,而且无论原理上还是实践中在安全性/副作用上比硝苯地平有优势。
血脂疗效评价:计算各组血总胆固醇和甘油三酯的平均数±标准差
表2 各药物对血脂的影响
总胆固醇mmol/L | 甘油三酯mmol/L | |
组1 | 7.2±1.7 | 2.2±1.5 |
组2 | 10.1±1.4 | 3.0±1.2 |
组3 | 7.4±1.3 | 2.1±2.0 |
从表2可以看出,虽然缺乏与实验开始时的数据的比较,仍然可以明确看出,杜仲降压片和本发明的中药组合物均有一定的降血脂作用,这方面效果优于硝苯地平片。
实施例3体内血栓形成实验
取40只SD大鼠(体重200-250g,雌雄各半),随机均分为5组;将丝线用生理盐水浸泡后称重,穿入聚乙烯管中,两端各留1cm,用60u/ml肝素灌注;大鼠禁食24h后灌胃药液/生理盐水;乙醚麻醉后,在颈总动脉处放置动脉夹,动脉将聚乙烯管两端插入颈动脉和颈外静脉;灌胃2h后,打开动脉夹,让血流流过插管;15min后取出插管内丝线和血凝块,吸干,称重,减去丝线重量即为血栓重量,计算各组的均数±标准差。
用药方案:
组1:厄贝沙坦片(赛诺菲),一片磨成粉,溶于250ml水中,取0.5ml灌胃;
组2:复方血栓通胶囊(广东众生药业股份有限公司),两个胶囊内的粉末,溶于250ml水,取0.5ml灌胃;
组3:灌胃0.5ml按实施例1制备的本发明中药组合物;
组4:灌胃0.5ml生理盐水;
实验结果:
表3:各种药物对血栓形成的影响
血栓重量mg | |
组1 | 7.28±1.44 |
组2 | 12.97±1.23 |
组3 | 10.56±2.61 |
组4 | 14.22±2.32 |
从表3可见:虽然效果不如专用的抗血栓西药,但本发明的中药组合物具有确切的抗血栓作用。尤其可贵的是,这种确切的抗血栓作用是在确切的降血压作用的同时实现的,目前并无有这两种确切效果的被中药公开。
Claims (4)
1.一种用于治疗高血压和血栓的中药组合物,包括以下重量份的原料:佛手3-9、黄芩3-10、香橼3-9、夏枯草9-15、酸枣仁9-15。
2.权利要求1所述的中药组合物,由以下重量份的原料药制成:佛手3-9、黄芩3-10、桑白皮5-15、牡蛎9-30、桑叶5-9、葛根9-15、白芍5-15、牛膝6-15、砂仁3-6、连翘6-15、香橼3-9、夏枯草9-15、栀子3-10、茵陈6-15、钩藤3-12、酸枣仁9-15、地骨皮6-15、玉竹6-12、桑寄生9-15。
3.权利要求2所述的中药组合物,由以下重量份的原料药制成:佛手5、黄芩10、桑白皮5、牡蛎25、桑叶5、葛根15、白芍15、牛膝10、砂仁3、连翘6、香橼3、夏枯草15、栀子10、茵陈9、钩藤3、酸枣仁9、地骨皮15、玉竹12、桑寄生9。
4.权利要求1-3任一项的中药组合物的制备方法,包括步骤:
按重量份称取各种药材;
将黄芩、牡蛎、葛根、夏枯草、茵陈、地骨皮加40%的乙醇提取3次,每次加醇量为药材总重量的10倍,每次提取时间为1.5小时,合并提取液,回收乙醇至无醇味,得到醇提液;将佛手、桑白皮、桑叶、白芍、牛膝、砂仁、连翘、香橼、栀子、钩藤、酸枣仁、玉竹、桑寄生加水提取3次,每次加水量分别为药材总重量的10倍量,每次提取时间为3小时,合并提取液,浓缩至相对密度为1.25,加入乙醇使含醇量为40体积%,混匀,放置24小时,取上清液,回收乙醇至无醇味,得到水提浓缩液;
将所得醇提液和水提浓缩液混合,得到中药组合物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610703425.8A CN106177057A (zh) | 2016-08-23 | 2016-08-23 | 一种治疗高血压和血栓的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610703425.8A CN106177057A (zh) | 2016-08-23 | 2016-08-23 | 一种治疗高血压和血栓的中药组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106177057A true CN106177057A (zh) | 2016-12-07 |
Family
ID=57524126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610703425.8A Pending CN106177057A (zh) | 2016-08-23 | 2016-08-23 | 一种治疗高血压和血栓的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106177057A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101152341A (zh) * | 2007-09-30 | 2008-04-02 | 陈宏刚 | 灵芝本草保健茶 |
CN102049010A (zh) * | 2010-12-30 | 2011-05-11 | 苏建峰 | 一种防治缺血性脑血管药物 |
CN104782830A (zh) * | 2014-01-21 | 2015-07-22 | 胡唐华 | 一种养生保健茶及其配方 |
-
2016
- 2016-08-23 CN CN201610703425.8A patent/CN106177057A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101152341A (zh) * | 2007-09-30 | 2008-04-02 | 陈宏刚 | 灵芝本草保健茶 |
CN102049010A (zh) * | 2010-12-30 | 2011-05-11 | 苏建峰 | 一种防治缺血性脑血管药物 |
CN104782830A (zh) * | 2014-01-21 | 2015-07-22 | 胡唐华 | 一种养生保健茶及其配方 |
Non-Patent Citations (2)
Title |
---|
张建平等: ""中西医结合治疗肝阳上亢型高血压60例临床小结"", 《现代中医药》 * |
朱进忠: "《中医内科证治备要》", 31 August 1983, 山西人民出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101869690B (zh) | 一种治疗气阴两虚型冠心病的中药制备方法 | |
CN103585478B (zh) | 一种治疗高血压的中药组合物 | |
CN104274789A (zh) | 一种治疗抑郁的中药组合物 | |
CN104758353B (zh) | 一种治疗心血管疾病的药物组合物及其制备方法和用途 | |
CN104435519B (zh) | 一种治疗原发性痛经的药物组合物 | |
CN103041339A (zh) | 一种治疗偏头痛的中药组合物及其制备方法 | |
CN101337017A (zh) | 一种治疗冠心病的药物 | |
CN101229345B (zh) | 益气补血药 | |
CN101433586B (zh) | 一种治疗缺血性脑血管疾病的药物及其制备方法 | |
CN101450189B (zh) | 一种治疗脑梗塞疾病的药物及其制备方法 | |
CN104147346A (zh) | 一种治疗冠脉弥漫性病变心绞痛的中药复方 | |
CN101664518B (zh) | 滋润浴液组合物、其制备方法及其在制备治疗阴血虚疲劳综合症肥胖症药品保健品中的应用 | |
CN102579804B (zh) | 一种治疗心绞痛的中药 | |
CN106177057A (zh) | 一种治疗高血压和血栓的中药组合物 | |
CN102274357B (zh) | 一种治疗冠状动脉硬化性心脏病的药物组合物及其制备方法 | |
CN101947299B (zh) | 一种治疗冠心病的药物组合物 | |
CN101664510B (zh) | 冲和浴液组合物、制备方法及在制备治疗寒热不著型疲劳综合症或肥胖症药品保健品中应用 | |
CN100998744A (zh) | 一种治疗小儿多动症的中成药 | |
CN101559161B (zh) | 一种中药组合物在制备治疗抑郁症药物中的应用 | |
CN110463799A (zh) | 一种护肝通便茶的野生植物组合物 | |
CN103599397B (zh) | 一种用于治疗慢性肾功能不全的中药组合物 | |
CN103768129A (zh) | 一种预防或治疗高血压的药物组合物 | |
CN103083483B (zh) | 一种治疗1、2级高血压病的中药组合物及其制备方法 | |
CN102698135B (zh) | 一种用于治疗三高症的中药组合物及其应用 | |
CN101244209B (zh) | 预防或治疗心脑血管疾病的药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161207 |